These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8393156

  • 21. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V, Karaivanov M, Marinov E, Gorchev G, Velkova A, Khristova P.
    Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Endometrial cancer after tamoxifen treatment: a descriptive study of 25 breast cancer patients who subsequently developed endometrial cancer.
    Peters-Engl C, Medl M, Danmayr E, Mirau M, Alth G, Leodolter S.
    Anticancer Res; 1996; 16(5B):3241-6. PubMed ID: 8920798
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Endometrial cancer within tamoxifen-related polyps in patients with breast cancer.
    Tate S, Yamazawa K, Sekiya S.
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):769-70. PubMed ID: 15255851
    [No Abstract] [Full Text] [Related]

  • 28. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
    Hoogendoorn WE, Hollema H, van Boven HH, Bergman E, de Leeuw-Mantel G, Platteel I, Fles R, Nederlof PM, Mourits MJ, van Leeuwen FE, Comprehensive Cancer Centers TAMARISK-group.
    Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
    [Abstract] [Full Text] [Related]

  • 29. Gynecologic surveillance of women on tamoxifen.
    Schwartz PE.
    Conn Med; 1994 Sep; 58(9):515-21. PubMed ID: 7956197
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group.
    J Natl Cancer Inst; 2005 Mar 02; 97(5):375-84. PubMed ID: 15741574
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y, Kurosumi M, Kobayashi Y, Tanuma J, Suemasu K, Higashi Y, Kasamatsu T, Shiromizu K, Matsuzawa M, Kishi K.
    Anticancer Res; 1996 Mar 02; 16(5A):2993-6. PubMed ID: 8917418
    [Abstract] [Full Text] [Related]

  • 38. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
    Magriples U, Naftolin F, Schwartz PE, Carcangiu ML.
    J Clin Oncol; 1993 Mar 02; 11(3):485-90. PubMed ID: 8383191
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tamoxifen and endometrial pathologies: a prospective study.
    Seoud M, Shamseddine A, Khalil A, Salem Z, Saghir N, Bikhazi K, Bitar N, Azar G, Kaspar H.
    Gynecol Oncol; 1999 Oct 02; 75(1):15-9. PubMed ID: 10502419
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.